Discovery is slow, expensive, and uncertain
Most natural candidates are ruled out late, after the budget is gone.
INDUSTRIES · PHARMA
Prioritize species, compounds, and mechanisms before the lab. Develop the candidate to extract, fraction, or molecule.
Most natural candidates are ruled out late, after the budget is gone.
Much of the region's flora has never been characterized, so it rarely enters a pipeline.
A promising candidate with no room to protect it is a candidate you can't move forward.
With the platform · Moka BDE
With a service
Every project starts with a question. These are the kind we hear.
No. Moka works in early discovery: prioritizing and developing candidates up to extract, fraction, or molecule.
Yes. We have a patent pending for an immunomodulator candidate identified through our discovery pipeline.
Predictions are hypotheses to prioritize. Our R&D service takes the selected candidates into the lab.
TRUST
Your data, your plants, and your results stay within your project.
Data, results, and IP are agreed with you, in writing.
Every plant traceable together with the communities.
Your next plant is waiting.